LivaNova (LIVN) Cash & Current Investments (2014 - 2026)
LivaNova recorded quarterly Cash & Current Investments of $578.0 million in Q1 2026, down 9.06% quarter-over-quarter from $635.6 million in Q4 2025, and down 21.72% year-over-year from $738.4 million in Q1 2025.
LivaNova's Cash & Current Investments history runs 13 years deep, the most recent figure standing at $578.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 21.72% year-over-year to $578.0 million; the TTM figure through Mar 2026 stood at $578.0 million (down 21.72% YoY), while the FY2025 annual figure was $635.6 million, up 48.2% from the prior year.
- Cash & Current Investments came in at $578.0 million for Q1 2026 at LivaNova, down from $635.6 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $738.4 million in Q1 2025 to a low of $223.2 million in Q2 2023.
- A 5-year average of $407.9 million and a median of $352.1 million in 2022 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments plunged 36.63% in 2023 and surged 109.71% in 2025, its largest moves.
- LivaNova's Cash & Current Investments stood at $357.2 million in 2022, then decreased by 14.61% to $305.0 million in 2023, then soared by 40.61% to $428.9 million in 2024, then jumped by 48.2% to $635.6 million in 2025, then fell by 9.06% to $578.0 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $578.0 million, $635.6 million, and $594.9 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 577.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 577.98 Mn |
| Dec 31, 2025 | 635.55 Mn |
| Jun 30, 2025 | 594.94 Mn |
| Mar 31, 2025 | 738.40 Mn |
| Dec 31, 2024 | 428.86 Mn |
| Sep 30, 2024 | 349.81 Mn |
| Jun 30, 2024 | 329.24 Mn |
| Mar 31, 2024 | 352.10 Mn |
| Dec 31, 2023 | 305.00 Mn |
| Sep 30, 2023 | 298.78 Mn |
| Jun 30, 2023 | 223.15 Mn |
| Mar 31, 2023 | 339.63 Mn |
| Dec 31, 2022 | 357.17 Mn |
| Sep 30, 2022 | 275.93 Mn |
| Jun 30, 2022 | 352.15 Mn |
| Mar 31, 2022 | 368.00 Mn |
| Dec 31, 2021 | 314.62 Mn |
| Sep 30, 2021 | 277.77 Mn |
| Jun 30, 2021 | 434.76 Mn |
| Mar 31, 2021 | 252.54 Mn |
| Dec 31, 2020 | 254.89 Mn |
| Sep 30, 2020 | 227.81 Mn |
| Jun 30, 2020 | 232.55 Mn |
| Mar 31, 2020 | 125.82 Mn |
| Dec 31, 2019 | 61.14 Mn |
| Sep 30, 2019 | 75.31 Mn |
| Jun 30, 2019 | 44.51 Mn |
| Mar 31, 2019 | 50.78 Mn |
| Dec 31, 2018 | 47.20 Mn |
| Sep 30, 2018 | 79.95 Mn |
| Jun 30, 2018 | 47.38 Mn |
| Mar 31, 2018 | 64.96 Mn |
| Dec 31, 2017 | 93.62 Mn |
| Sep 30, 2017 | 65.16 Mn |
| Jun 30, 2017 | 42.69 Mn |
| Mar 31, 2017 | 62.72 Mn |
| Dec 31, 2016 | 39.79 Mn |
| Sep 30, 2016 | 63.63 Mn |
| Jun 30, 2016 | 70.89 Mn |
| Mar 31, 2016 | 94.46 Mn |
| Dec 31, 2015 | 119.61 Mn |
| Oct 18, 2015 | 196.78 Mn |
| Jul 24, 2015 | 162.36 Mn |
| Apr 24, 2015 | 151.21 Mn |
| Oct 24, 2014 | 116.84 Mn |
| Apr 25, 2014 | 124.19 Mn |